In my head, I always put them in a bucket with Theranos and uBeam, Startups who made product claims which experts in their fields said were not possible.
I guess slick marketing wins over those doubts in some VC circles but you wonder if anyone at the early stage Magic Leap investors is getting asked tough questions about why they approved it, or if they've all just moved on to other roles.
I would guess this depends on whether or not they managed to hoist the stock to someone else in subsequent rounds. Investing in a scam can still be a good deal, as long as you get out before the jig is up